Grove Place Surgery Center: Alleged Lesions, Mohs Stages and Repairs

Grove Place Surgery Center and the physician who managed it agreed to pay $4 million in a Mohs fraud settlement over allegations that they billed Medicare for unnecessary or unperformed surgery. For someone who saw the referrals, handled the tissue or worked on the claims, the allegations reach three separate parts of the encounter: the cancer said to need removal, the stages of surgery and the repair afterward.

The physician practiced Mohs and facial plastic surgery in Vero Beach, Florida, and managed Grove Place as an ambulatory surgical center. In its June 17, 2015 announcement, the Justice Department described a case brought by a referring surgeon and a histology technician. Their work put them on different sides of the same clinical story.

Additional Lesions Without a Confirmed Cancer

The government alleged that the physician routinely told patients referred with a confirmed skin cancer lesion that they had additional lesions requiring Mohs surgery. According to the government, those additional lesions had not been confirmed as cancerous through a biopsy or simply did not exist.

That allegation puts the reason for surgery at the center of the medical necessity fraud case. A patient arrived with a confirmed lesion, and the physician allegedly added other sites for treatment. For a referring clinician, the useful comparison is between the cancer that prompted the referral and the additional lesions used to justify surgery. The biopsy and clinical account bear directly on what Medicare was asked to pay for.

More Mohs Stages Meant More Surgery

Mohs surgery removes tissue in stages, with a microscopic examination between removals. The surgeon removes a layer, examines the excised tumor and performs another stage if needed, continuing until the cancer has been removed.

The government alleged that the Grove Place physician routinely performed three or four stages, and sometimes many more, solely to increase Medicare reimbursement. It said those stages were often unnecessary and required patients to remain at the center for prolonged periods and undergo additional surgery they did not need.

We see patients and taxpayers paying for the same alleged scheme: patients with unnecessary surgery, taxpayers with Medicare money. The tissue examined between stages is where that financial story meets the clinical one. What the microscopic examination showed, and why another layer was removed, matter to the claim for the next stage.

The Repair Claims Had Their Own Problem

The government also alleged that the physician routinely billed Medicare for unnecessary or nonexistent adjacent tissue transfers after the claimed Mohs surgeries. These are complicated, often time-consuming reconstructions used to close a skin defect left by removing a lesion.

According to the government, the physician billed for these repairs in connection with virtually every Mohs surgery he claimed to have performed. It alleged that, in most cases, performing them would have been physically impossible. We see the absurdity: the bills described work the government said the physician could not physically have done. An insider who knew the wound and the reconstruction could speak to a different question from the person who knew the biopsy: what repair actually occurred?

A later procedure upcoding case shows another way the repair can change the bill. In the Forefront Dermatology and Henghold Surgery Center settlement, announced in July 2025, the government alleged that linear repairs after Mohs were coded as flap repairs and smaller flaps as larger ones. There, the alleged discrepancy concerned the kind or extent of reconstruction represented to Medicare. At Grove Place, the government questioned whether the billed reconstructions were necessary or had happened at all.

Two Insiders Saw Different Parts of the Work

The Grove Place whistleblowers were a facial plastic surgeon who had previously performed Mohs surgery and referred patients to the physician, and a histology technician who had worked for him for more than eight years. They brought the case under the False Claims Act. The referring surgeon’s clinical perspective and the technician’s tissue-processing perspective reached different parts of the work behind the claims.

The Journal of AHIMA’s 2017 article Busting Bad Medicine: a Call to Action Addressing Healthcare, Fraud, Waste, and Abuse describes checking treatment dates, treatment types and clinician signatures against the patient’s health record. It then makes a point that fits the complementary roles in this case:

The Settlement and the Whistleblower Case

The government joined the whistleblowers’ case and took primary responsibility for pursuing it. The Southern District of Florida U.S. Attorney’s Office, the Department of Health and Human Services’ Office of Inspector General, the FBI and the Defense Criminal Investigative Service coordinated the effort that produced the settlement. The physician also agreed to exclusion from Medicare, Medicaid and all federally funded health care programs for at least five years.

The announcement said the referring surgeon and histology technician would share a whistleblower reward. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

What Evidence Does a Whistleblower Need?

For a Mohs case like this one, evidence connects the lesion, tissue examination, surgical stages and repair to the Medicare claim. We work with the insider to understand where the clinical account and the billing part company. Someone who knows the tissue-processing work may explain a discrepancy that would be difficult to see from claim lines alone.

The working record matters at each stage. A biopsy bears on the alleged cancer, the tissue examination bears on further removal, and the wound and operative account bear on reconstruction. That is why we connect the clinical records with the claim and the people who can explain the encounter.

A different Mohs settlement illustrates why the comparison also follows the person doing the work. In its July 2023 settlement with Skin Cancer & Cosmetic Dermatology Center and its physician, the government alleged that procedures were billed as though the physician had performed both surgery and pathology when others performed at least one part. It also alleged billing that avoided the payment reduction for multiple procedures on the same patient on the same day. The comparison follows who did the work as well as whether the work happened at all.

You Know the Work Behind the Mohs Claim

If you saw additional lesions appear in the treatment account, handled the specimens or questioned the repair claims, speak to one of our whistleblower experts about the claims you saw. We build the case with you and bring in healthcare fraud whistleblower lawyers who understand physician billing and clinical evidence. We stay alongside you to turn that inside knowledge into your strongest Mohs whistleblower case.